Cargando…

Brain Injury Markers: Where are We?

Detalles Bibliográficos
Autores principales:	Mondello, Stefania, Tortella, Frank C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120680/ https://www.ncbi.nlm.nih.gov/pubmed/25136331 http://dx.doi.org/10.3389/fneur.2014.00145

Ejemplares similares

A Military-Centered Approach to Neuroprotection for Traumatic Brain Injury
por: Shear, Deborah A., et al.
Publicado: (2013)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study
por: Mondello, Stefania, et al.
Publicado: (2011)

Deep Brain Stimulation for Parkinson's Disease: Where Do We Stand?
por: Albanese, Alberto, et al.
Publicado: (2011)

Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury
por: Hasan, Anwarul, et al.
Publicado: (2017)

Hearing Loss and Cognition: What We Know and Where We Need to Go
por: Powell, Danielle S., et al.
Publicado: (2022)

Surgically-induced brain injury: where are we now?
por: Travis, Zachary D., et al.
Publicado: (2019)

Where will the (New) Drugs for Traumatic Brain Injury Treatment be Coming From?
por: Agoston, Denes V., et al.
Publicado: (2012)

The Hippocampus and Imagining the Future: Where Do We Stand?
por: Addis, Donna Rose, et al.
Publicado: (2012)

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
por: Mejzini, Rita, et al.
Publicado: (2019)

Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
por: Barros, Inês, et al.
Publicado: (2020)

The peritumoral brain zone in glioblastoma: where we are and where we are going
por: Giambra, Martina, et al.
Publicado: (2022)

Brain Metabolite Diffusion from Ultra-Short to Ultra-Long Time Scales: What Do We Learn, Where Should We Go?
por: Valette, Julien, et al.
Publicado: (2018)

The Diagnosis of Traumatic Brain Injury on the Battlefield
por: Schmid, Kara E., et al.
Publicado: (2012)

Brain biomarkers and brain tissue oxygenation: changes and correlations following severe head injury
por: Mondello, S, et al.
Publicado: (2010)

Early brain injury and subarachnoid hemorrhage: Where are we at present?
por: Chowdhury, Tumul, et al.
Publicado: (2013)

Decoding methods for neural prostheses: where have we reached?
por: Li, Zheng
Publicado: (2014)

Editorial: Representational states in memory: where do we stand?
por: Öztekin, Ilke, et al.
Publicado: (2015)

Music and the Auditory Brain: Where is the Connection?
por: Nelken, Israel
Publicado: (2011)

Systematic Reviews in Occupational Health and Safety: where are we and where should we go?
por: Verbeek, Jos, et al.
Publicado: (2019)

Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review
por: Thelin, Eric Peter, et al.
Publicado: (2017)

Neural Information Processing in Cognition: We Start to Understand the Orchestra, but Where is the Conductor?
por: Palm, Günther
Publicado: (2016)

Improvements to Healthspan Through Environmental Enrichment and Lifestyle Interventions: Where Are We Now?
por: Queen, Nicholas J., et al.
Publicado: (2020)

Assessing Neuro-Systemic & Behavioral Components in the Pathophysiology of Blast-Related Brain Injury
por: Kobeissy, Firas, et al.
Publicado: (2013)

Implantable Hearing Aids: Where are we in 2020?
por: Banakis Hartl, Renee M., et al.
Publicado: (2020)

The Role of Markers of Inflammation in Traumatic Brain Injury
por: Woodcock, Thomas, et al.
Publicado: (2013)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Neurotrophic Growth Factors for the Treatment of Amyotrophic Lateral Sclerosis: Where Do We Stand?
por: Henriques, Alexandre, et al.
Publicado: (2010)

The Maze of APP Processing in Alzheimer’s Disease: Where Did We Go Wrong in Reasoning?
por: Chen, Ming
Publicado: (2015)

Evaluating Circadian Dysfunction in Mouse Models of Alzheimer’s Disease: Where Do We Stand?
por: Sheehan, Patrick W., et al.
Publicado: (2020)

In vivo Genome Editing Therapeutic Approaches for Neurological Disorders: Where Are We in the Translational Pipeline?
por: Lubroth, Pablo, et al.
Publicado: (2021)

Dermatology: Where are We Coming from and Where are We Going to?
por: van de Kerkhof, Peter C. M.
Publicado: (2014)

Editorial: Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?
por: Misiak, Błazej, et al.
Publicado: (2019)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019)

tDCS of the Cerebellum: Where Do We Stand in 2016? Technical Issues and Critical Review of the Literature
por: van Dun, Kim, et al.
Publicado: (2016)

Recanalization and Reperfusion Therapies of Acute Ischemic Stroke: What have We Learned, What are the Major Research Questions, and Where are We Headed?
por: Gomis, Meritxell, et al.
Publicado: (2014)

Auditory and visual systems organization in Brodmann Area 8 for gaze-shift control: where we do not see, we can hear
por: Lanzilotto, Marco, et al.
Publicado: (2013)

Diversity in orthopaedic trauma: where we are and where we need to be
por: Ortega, Gil, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders
por: Constantinescu, Radu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lcbvdsg02ke5l1srprv5mkkjoh